Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis

National Taiwan University Hospital200 enrolled

Overview

We wish to study radiation therapy in uterine cancer, focusing on dosimetry analysis, clinical implication, and survival analysis.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Endometrial Cancer

Interventions

Observational studyOTHER

Observational study

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women with uterine cancer (stage I - IV) treated in National Taiwan University Hospital, from January 2010 to September 2019. Exclusion Criteria: * Women with uterine cancer (stage I - IV) NOT treated in National Taiwan University Hospital, from January 2010 to September 2019.

Outcomes

Primary Outcomes

Progression free survival

Progression free survival: The time from inclusion to documented disease progression according to RECIST v1.1 or death from any cause.

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.